|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.6 EUR | 0.00% |
|
-1.10% | -20.35% |
| Apr. 02 | Shedir Pharma, into 2023 with rising revenues; profit down single digits | AN |
| Mar. 29 | Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Shedir Pharma Group S.p.A. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 23.3 million compared to EUR 18.55 million a year ago. Revenue was EUR 23.76 million compared to EUR 19.03 million a year ago.
Net income was EUR 0.987 million compared to EUR 0.681 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -20.35% | 43.83M | |
| +26.47% | 664B | |
| +26.74% | 567B | |
| -6.33% | 354B | |
| +19.35% | 330B | |
| +4.23% | 286B | |
| +13.43% | 234B | |
| +4.71% | 199B | |
| -9.53% | 196B | |
| -4.04% | 148B |
SHEDIR PHARMA GROUP S.P.A. 
